SGX to boost freight derivatives with pursuit of Baltic Exchange


Boosting operations: An employee works at a front desk of the Singapore Exchange head office. The bourse has struggled in recent years, losing out to Hong Kong as the main destination for large initial public offerings in the region and the proposed acquisition of Baltic Exchange is one of several efforts by new CEO Loh Boon Chye to revive its fortunes. — Reuters

SINGAPORE: Singapore Exchange’s (SGX) bid to buy London’s Baltic Exchange is aimed at burnishing its derivatives credentials among ship brokers and commodity merchants, fitting hand in glove with its efforts to develop Asian pricing benchmarks for bulk commodities.

The bourse has struggled in recent years, losing out to Hong Kong as the main destination for large initial public offerings (IPOs) in the region and the proposed acquisition is one of several efforts by new CEO Loh Boon Chye to revive its fortunes.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Business , SGX , baltic exchange , stocks , shares ,

   

Next In Business News

ViTrox optimistic on semiconductor sector growth
Pavilion REIT’s 1Q net profit rises to RM83.2mil
Martijn Rene van Keulen to helm Heineken Malaysia from July 1
OCK proposed RM500mil ICP programme
Profit-taking in the market, KLCI down 0.14%
EPF balancing between retirement mandate and supporting members' economic survival
Asian stocks hit by US tech slide, FX subdued
CelcomDigi emphasises its significant role in protecting customers from AI-related risks
China's largest auto show showcases all-electric future, local brands dominate
Unilever beats first quarter sales forecasts, sticks to 2024 outlook

Others Also Read